	2016 Mar 31	2017 Mar 31	R 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Total Revenue	475	545	647	761	856	998	1,228	1,148	1,208	1,331	1,646
Cost of Operating Revenue	152	164	181	210	263	316	360	363	367	407	481
Gross Profit	323	381	467	551	594	682	869	785	841	924	1,165
Gross Margin	67.9	69.9	72.1	72.4	69.3	68.4	70.7	68.3	69.6	69.4	70.8
Total Operating Expenses	364	409	485	581	683	755	947	945	1,013	1,136	1,379
Operating Profit	111	136	162	180	173	243	282	204	195	196	267
Operating Margin	23.4	24.9	25.1	23.7	20.2	24.3	22.9	17.7	16.2	14.7	16.2
Financing Income/(Expense) - Net	0	6	1	4	-2	0	-9	-22	-24	-12	-25
Profit before Taxes	124	157	164	188	169	244	293	188	175	191	259
Income Taxes	46	53	52	63	41	61	79	44	46	45	68
Profit after Tax	77	102	104	120	127	183	214	143	128	145	190
PAT Margin	16.2	18.7	16.1	15.8	14.9	18.3	17.4	12.4	10.6	10.9	11.5
EPS - Basic - ex Extraordinary Items	3.83	5.06	5.25	6.02	6.34	8.99	10.47	6.98	6.24	7.07	9.19
EPS - Diluted - ex Extraordinary Items	3.83	5.06	5.22	6.00	6.31	8.95	10.41	6.95	6.22	7.04	9.19
EBIT	111	136	162	180	173	243	282	204	195	196	267
EBITDA	128	153	181	200	212	289	345	293	290	304	401
EBITDA Margin	26.9	28.1	28.0	26.3	24.8	28.9	28.1	25.5	24.0	22.9	24.4

Balance Sheet

Abridged

Understanding Balance Sheet

Metropolis Healthcare Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	PR	PR	PR	AR	AR	AR	AR	AR	AR	AR	PRESS
Total Current Assets	225	285	301	305	397	608	393	303	316	346	469
Long-Term Investments	2	4	10	2	3	2	2	2	6	7	22
Property Plant & Equipment - Net	106	106	112	117	181	218	249	311	336	361	410
Total Non-Current Assets	171	230	230	248	355	396	1,137	1,199	1,239	1,521	1,669
Total Assets	396	515	530	553	752	1,004	1,530	1,502	1,555	1,867	2,138
Total Current Liabilities	91	152	91	124	169	204	302	265	246	294	334
Long Term Debt	0	0	0	0	46	79	241	154	119	112	138
Total Non-Current Liabilities	11	19	11	8	58	92	341	246	210	238	279
Total Liabilities	102	171	101	133	227	296	642	511	456	533	613
Total Shareholders' Equity	279	323	415	419	523	707	886	988	1,096	1,331	1,513
Minority Interest	15	21	14	1	2	1	2	2	3	4	11
Total Equity	294	344	429	420	525	708	888	991	1,099	1,335	1,525
Total Liabilities & Equity	396	515	530	553	752	1,004	1,530	1,502	1,555	1,867	2,138

Cash Flow

Abridged

Understanding Cash Flow Statement

Metropolis Healthcare Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M PR	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	96.16	113.80	129.94	143.83	183.41	267.46	278.35	219.16	238.30	261.48	381.38
Working Capital - Increase/(Decrease)	-0.42	-3.90	-23.14	-50.78	27.97	-15.31	-32.40	7.11	5.45	-15.71	-53.22
Net CF from Operating Activities	95.74	109.90	106.80	93.04	211.38	252.15	245.95	226.27	243.76	245.77	328.16
Capital Expenditures - Net	10.69	15.79	18.21	23.48	35.94	28.19	30.66	52.48	63.76	66.61	50.91
Net CF from Investing Activities	91.24	-94.10	-1.04	32.32	-108.96	51.27	-748.64	40.29	-91.58	-202.63	-224.99
Dividends Paid - Cash - Total	-	-	-	66.54	40.14	40.89	40.94	40.97	20.50	-	20.73
Stock - Issuance/(Retirement) - Net	-	-	-	2.57	31.89	34.32	1.97	0.18	0.00	0.01	6.57
Debt - LT & ST - Issuance/(Retirement) - Total	-5.67	-3.76	-0.27	17.05	-31.07	-17.98	220.93	-224.22	-138.23	-68.09	-76.73
Net Cash Flow from Financing Activities	-172.97	-17.14	-87.25	-118.02	-47.57	-25.38	180.90	-265.00	-158.72	-68.08	-90.89
Free Cash Flow to Equity	79.38	90.36	88.33	86.61	144.36	205.98	436.22	-50.44	41.77	111.07	200.52
Free Operating CF net dividend	79.02	93.31	86.91	2.76	135.03	182.98	174.35	132.66	159.50	177.15	256.25
Free Operating CF	79.02	93.31	86.91	69.30	175.17	223.88	215.29	173.63	179.99	177.15	276.98

Business Segment Analysis

FY End:

Mar 25

Metropolis Healthcare Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Pathology service (100.0%)₹ 68.61 Cr

Revenue / Sales

Pathology service (100.0%)₹ 1,331.20 Cr

Assets

Pathology service (100.0%)₹ 1,867.34 Cr

Operating Income

Pathology service (100.0%)₹ 195.64 Cr

Regional Segment Analysis

FY End:

Mar 25

Metropolis Healthcare Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

India (91.8%)₹ 1,221.81 CrOutside India (8.2%)₹ 109.39 Cr

Historical Segment Analysis

Track how Metropolis Healthcare Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31

Pathology service	36	28	31	53	64	69

Frequently Asked Questions

What is the revenue of Metropolis Healthcare Ltd.?

The latest trailing twelve month revenue of Metropolis Healthcare Ltd. is ₹ 1,645.85 Cr, reflecting a 1-year growth of 23.64% and a 3-year CAGR of 12.75%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Metropolis Healthcare Ltd.?

The latest trailing twelve month net profit (PAT) of Metropolis Healthcare Ltd. is ₹ 190.02 Cr, with a 3-year earnings CAGR of 9.74%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Metropolis Healthcare Ltd.?

The trailing twelve month EBITDA of Metropolis Healthcare Ltd. is approximately ₹ 267.12 Cr (based on an operating margin of 16.23%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Metropolis Healthcare Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Metropolis Healthcare Ltd. is 9.19. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Metropolis Healthcare Ltd.?

The debt-to-equity ratio of Metropolis Healthcare Ltd. stands at 0.15. The interest coverage ratio is 10.88x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Metropolis Healthcare Ltd.?

The estimated book value per share of Metropolis Healthcare Ltd. is 74.54 (derived from a P/B ratio of 7.46 and market price of ₹ 555.95), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Metropolis Healthcare Ltd.?

The trailing twelve month operating cash flow of Metropolis Healthcare Ltd. is ₹ 328.16 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Metropolis Healthcare Ltd. report consolidated or standalone financials?

Metropolis Healthcare Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.